Skip to content

?Study on the role of Homoeopathy in the management of Migraine: understanding the link between patient?s miasmatic background and choice of medicine?

A retrospective observational cohort study to correlate miasm with posology in the homeopathic management of migraine - MPM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093923
Enrollment
30
Registered
2025-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system Health Condition 2: G40-G47- Episodic and paroxysmal disorders Health Condition 3: -

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

S.S.AGRAWAL HOMOEOPATHIC MEDICAL COLLEGE & HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed with migraine according to International Classification of Headache Disorders (ICHD-3) criteria. Age group: 15 to 55 years. Both male and female participants.

Exclusion criteria

Exclusion criteria: Patients below 15 years of age. Pregnant and lactating women. Patients with severe systemic illness (e.g., uncontrolled diabetes, hypertension, cardiac disease) or comorbid neurological/psychiatric conditions that may interfere with the study outcomes.

Design outcomes

Primary

MeasureTime frame
To correlate miasmatic background with posology (potency selection and repetition of dose) in the homoeopathic management of migraine, assessed using the Migraine Disability Assessment Scale (MIDAS) over a period of 12 months.Timepoint: Outcome will be assessed at baseline, 3 months, and 6 months, with final evaluation at 12 months of follow-up.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR.RAMESH GUPTA

S.S.AGRAWAL HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

drrameshgupta794@gmail.com9867412109

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026